Jak Pharmalab Private Limited

Jak Pharmalab Private Limited - healthcare in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U51909MH2017PTC292011 Incorporated 06 March 2017 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Private Limited Company healthcare
Data last updated
Revenue · FY 2024
₹1.82 Cr
▼ 31% YoY
Net profit · FY 2024
₹1.06 Lakh
Net margin 0.6%
EBITDA · FY 2024
₹9.45 Lakh
EBITDA margin 5.2%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹48 Lakh
Secured borrowings
Company age
9 yrs
Est. 2017
Directors on board
2
As per MCA filings

About Jak Pharmalab Private Limited

Data last updated:

Jak Pharmalab Private Limited is a private limited company based in Mumbai, Maharashtra, India, recognised as a startup by DPIIT. It operates in the medical consumables and supplies segment of the healthcare sector. It was incorporated on 06 March 2017 and has been in existence for over 9 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51909MH2017PTC292011. Its GSTIN is 27AADCJ9074H1Z8 (Maharashtra).

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Abhijit Kshitish Chowdhary and Hasi Abhijit Chowdhury.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.

As per the financials filed for FY 2024, the company reported a revenue of ₹1.82 Cr, a decline of 31% compared to the previous year. For the same year it recorded a net profit of ₹1.06 Lakh (net margin 0.6%) and EBITDA of ₹9.45 Lakh (EBITDA margin 5.2%). Revenue has grown at a compounded annual rate (CAGR) of 12% over three years and 22% over five years.

As per MCA filings, the company has open charges of ₹48 Lakh on record.

The current compliance status is marked as compliant by the Registrar of Companies.

Company Details of Jak Pharmalab Private Limited
CIN U51909MH2017PTC292011
Registration Number 292011
Incorporation Date 06 March 2017
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
DPIIT Recognition Recognised Startup
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    Gala No 109 1st Floor Khyati Industrial Esta, Laxmi Nagar Link Road, Mumbai, Maharashtra, India – 400104
  • Industry
    Healthcare, Medical Consumables & Supplies
Comprehensive company report
Jak Pharmalab Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Jak Pharmalab Private Limited report

Financials, compliance, directors, charges, ownership and filings for Jak Pharmalab Private Limited in one report.

Financials from FY 2017 Directors & ownership Charges & compliance

Business Activity of Jak Pharmalab Private Limited

The main business activity of Jak Pharmalab is trade. In detail, this covers wholesale trading.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
GTradeG1Wholesale TradingLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Jak Pharmalab Private Limited FY 2025 filings available

Jak Pharmalab Private Limited reported revenue of ₹1.82 Cr (down 31% YoY) for FY 2024.

Revenue · FY 2024
₹1.82 Cr ▼ 31%
Net profit · FY 2024
₹1.06 Lakh margin 0.6%
EBITDA · FY 2024
₹9.45 Lakh margin 5.2%

Compounded Annual Growth Rate (CAGR) of Jak Pharmalab Private Limited

Revenue CAGR growth
1 year
▼ 31%
3 years · compounded
▼ 12%
5 years · compounded
▲ 22%
EBITDA CAGR growth
1 year
▲ 75%
3 years · compounded
▲ 64%
5 years · compounded
▲ 98%

Revenue fell 31% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 22%. EBITDA rose 75% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Jak Pharmalab Private Limited

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations••••••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue••••••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA₹9.45 Lakh••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)₹1.06 Lakh••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Jak Pharmalab Private Limited

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin5.2%••••••••••••••••
Net Profit Margin0.6%••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Jak Pharmalab are in the company report.

Premium access

Financial statements from FY 2017

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Peer Comparison of Jak Pharmalab Private Limited

Jak Pharmalab Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Genirex Healthcare Private Limited₹1.83 Cr (FY 2024)••••••••-1.0%••••Mumbai, Maharashtra, India
Balasia Pharmaceuticals Private Limited₹1.83 Cr (FY 2025)••••••••12.0%••••Kolkata, West Bengal, India
Palas Pharmaceuticals Private Limited₹1.83 Cr (FY 2024)••••••••-15.0%••••Lucknow, Uttar Pradesh, India
Medreich Life Care Limited₹1.83 Cr (FY 2022)••••••••-47.0%••••Bangalore, Karnataka, India
Acurela Pharms Limited₹1.83 Cr (FY 2025)••••••••54.0%••••Bangalore, Karnataka, India
Jak Pharmalab Private Limited this company₹1.82 Cr (FY 2024)••••••••-31.0%••••Mumbai, Maharashtra, India
Carneo Pharma (OPC) Private Limited₹1.82 Cr (FY 2025)••••••••214.0%••••Pune, Maharashtra, India
SM Traders Private Limited₹1.82 Cr (FY 2025)••••••••68.0%••••Ernakulam, Kerala, India
Sinopharm India Private Limited₹1.82 Cr (FY 2024)••••••••-66.0%••••New Delhi, Delhi, India
Dr. Sidhan`S Ayurmix Private Limited₹1.81 Cr (FY 2025)••••••••-1.0%••••Chennai, Tamil Nadu, India
Savita Biotech Private Limited₹1.81 Cr (FY 2025)••••••••3.0%••••Vijayawada, Andhra Pradesh, India

Peers are the five companies nearest above and the five nearest below Jak Pharmalab by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Auditor Details of Jak Pharmalab Private Limited

Jak Pharmalab Private Limited is audited by Rajesh Gada & Associates for the financial year 2023.

NameStatusAppointment DateCessation Date
Rajesh Gada & AssociatesLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Jak Pharmalab Private Limited

Jak Pharmalab has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Abhijit Kshitish ChowdharyDirector06 Mar 20179 Years 7 MonthsCurrent
Hasi Abhijit ChowdhuryDirector06 Mar 20179 Years 7 MonthsCurrent

Ownership and Shareholding of Jak Pharmalab Private Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Jak Pharmalab Private Limited

Open charges
₹48 Lakh
Satisfied charges
None
Breakdown by lending institutions
Bank of India₹0.48 Cr
Latest charge details
DateLenderAmountStatus
14 Aug 2020Bank of India₹48 LakhOpen

Total charge records: 1 View all charges

Employees and EPFO Compliance at Jak Pharmalab Private Limited

Employment history and EPFO contributions of people linked to Jak Pharmalab.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Jak Pharmalab Private Limited

Jak Pharmalab Private Limited has 2 board changes on record since 2017: 2 appointments. The latest: Abhijit Kshitish Chowdhary was appointed as Director on 06 Mar 2017.

AGM
Jak Pharmalab Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Jak Pharmalab Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Charges
A charge with Bank Of India amounted to Rs. 48.00 Lakh with Charge ID 100365735 was registered on 14 Aug 2020.
Appointed
Abhijit Kshitish Chowdhary was appointed as Director.
Appointed
Hasi Abhijit Chowdhury was appointed as Director.
Incorporation
06 Mar 2017
Jak Pharmalab Private Limited was registered on 06 Mar 2017 with Roc Mumbai I & aged 9 years 7 months as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts for Jak Pharmalab Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Jak Pharmalab Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Jak Pharmalab Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Jak Pharmalab Private Limited

Jak Pharmalab has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
27AADCJ9074H1Z8MaharashtraActive28 Jul 2017
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Jak Pharmalab Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jak Pharmalab Private Limited

Jak Pharmalab is an active private limited company based in Mumbai, Maharashtra, India. The company works in medical consumables and supplies, within the healthcare industry. It was incorporated on 06 March 2017 (9+ years old) and is registered under CIN U51909MH2017PTC292011.

Jak Pharmalab reported revenue of ₹1.82 Cr for FY 2024 (down 31% YoY).

Jak Pharmalab has 2 current directors:

Jak Pharmalab reported a net profit of ₹1.06 Lakh (net margin 0.6%) and EBITDA of ₹9.45 Lakh (EBITDA margin 5.2%) for FY 2024, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of Jak Pharmalab is -12% over three years and 22% over five years. In the latest year (FY 2024) revenue fell 31%. CAGR is the steady yearly rate that links the first and the last year.

The GSTIN of Jak Pharmalab is 27AADCJ9074H1Z8, registered in Maharashtra.

The CIN (Corporate Identification Number) of Jak Pharmalab is U51909MH2017PTC292011. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Jak Pharmalab was incorporated on 06 March 2017, making it 9+ years old. It is registered with the Registrar of Companies, Mumbai.

The peers of Jak Pharmalab by revenue are Genirex Healthcare Private Limited, Balasia Pharmaceuticals Private Limited, Palas Pharmaceuticals Private Limited, Medreich Life Care Limited, Acurela Pharms Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).

Abhijit Kshitish Chowdhary was appointed as Director on 06 Mar 2017. Hasi Abhijit Chowdhury was appointed as Director on 06 Mar 2017.

Yes, Jak Pharmalab is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available